GoodRx raises 2026 outlook to $765M-$785M revenue and at least $235M adjusted EBITDA, led by Pharma Direct
GoodRx Holdings, Inc. Class A Common Stock · SERVICES-COMPUTER PROCESSING & DATA PREPARATION · Now $3.08
-14% in 7d after detection
Post-detection moves
1h
—
1d
-2.7%
3d
-11%
7d
-14%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS